Current considerations for the management of musculoskeletal pain in Asian countries: a special focus on cyclooxygenase-2 inhibitors and non-steroid anti-inflammation drugs
International Journal of Rheumatic Diseases, 08/17/2012
Pongparadee C et al. – The authors have identified a number of unmet therapeutic needs and prioritized initiatives with the potential to contribute toward a more integrated approach to chronic pain management. Key priorities included using evidence–based interventions as recommended by current guidelines, particularly those aspects pertinent to addressing treatment priorities in Asia, and the incorporation of cyclooxygenase–2 inhibitors and non–steroid anti–inflammation drugs into the management algorithms for osteoarthritis and rheumatoid arthritis. Treatment must be individualized for each patient based on efficacy, side–effect profile and drug accessibility.
